主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MGNX
#3184
MacroGenics, Inc.
1.9
9
+1.53%
版块:
基础:
利润货币:
日范围
年范围
日变化
+1.53%
每月变动
+8.15%
6个月变化
+13.71%
年变化
-17.43%
前一天收盘价
1.9
6
Open
1.9
9
Bid
Ask
Low
1.9
9
High
1.9
9
交易量
16
市场
股票
医疗保健
MGNX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
56.26 M
61.32 M
61.84 M
62.43 M
63.09 M
—
Valuation ratios
Enterprise value
1.1 B
860.79 M
284.41 M
534.6 M
22.2 M
-71.3 M
Price to earnings ratio
—
-4.76
-3.26
-67.87
-3.04
-8.05
Price to sales ratio
—
12.42
2.57
10.73
1.36
3.17
Price to cash flow ratio
—
-6.69
-4.49
-8.06
-2.98
-5.83
Price to book ratio
—
4.02
2.75
4.13
1.75
2.52
Enterprise value to EBITDA ratio
—
37.36
2.8
34.06
0.26
-0.59
Profitability ratios
Return on assets %
0.34
0.6
0.43
0.03
0.26
0.02
Return on equity %
0.44
0.84
0.84
0.06
0.58
0.71
Return on invested capital %
338.26
510.33
323.56
442.07
386.54
—
Gross margin %
100
96.58
97.79
98.95
99.44
398.8
Operating margin %
124.96
261.85
79.91
286.38
73.74
226.96
EBITDA margin %
—
29.75
66.81
26.72
57.12
153.49
Net margin %
123.7
260.97
78.82
15.42
44.66
-5.08
Liquidity ratios
Quick ratio
—
3.69
4.54
4.46
3.92
17.07
Current ratio
6.17
3.75
4.57
4.48
3.92
17.68
Inventory turnover
—
0.6
1.15
0.46
1.39
0.14
Asset turnover
0.3
0.22
0.49
0.2
0.54
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
2.4
1.42
1.26
1.09
2.58
EBIT per share
—
0.2
1.46
0.1
1.25
1.1
EBITDA per share
—
0.38
1.65
0.25
1.37
1.22
Total debt per share
—
—
—
—
—
—
Cash per share
—
2.06
1.77
1.63
2.92
8.57
Net current asset value per share
—
4.66
3.62
4.06
3.47
13.28
Tangible book value per share
—
4
2.31
2.46
1.85
4.91
Working capital per share
—
3.42
2.83
3.15
2.59
10.19
Book value per share
—
4
2.31
2.46
1.85
4.91
新闻
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
FDA部分临床暂停后MacroGenics股价下跌
MacroGenics stock falls after FDA places partial clinical hold
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
MacroGenicsQ3每股收益及营收超出预期
MacroGenics Inc earnings beat by $0.68, revenue topped estimates
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates